Home › Soft Tissue Sarcoma › California › San Francisco
Soft Tissue Sarcoma clinical trials in San Francisco, CA
5 studies for Soft Tissue Sarcoma are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPhase 1
- University of California, San Francisco (UCSF), San Francisco
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
RecruitingPhase 1
- University of California San Francisco, San Francisco
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- University of California, San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
Prospective Registry of Histotripsy for Soft Tissue Tumors
RecruitingObservational study
- University of California, San Francisco, San Francisco
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX32 studies
- New York City, NY20 studies
- Boston, MA18 studies
- St. Louis, MO14 studies
- Los Angeles, CA13 studies
- Columbus, OH13 studies
- Washington, DC12 studies
- Memphis, TN11 studies
- Philadelphia, PA10 studies
- Queens, NY9 studies
- Rochester, MN9 studies
- Aurora, CO9 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Metastatic Cancer29 studies
- Heart Failure29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Ovarian Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.